Clinical Studies of Oestrogen Therapy for Dementia

Abstract

The positive effects of oestrogen on the maintenance of brain function and the prevention of Alzheimer's disease (AD) have recently been reported. Oestrogen is considered to 1) improve depression, 2) increase brain blood flow, 3) stimulate neuronal function, 4) increase the number of developed gliacytes, and 5) suppress amyloid deposition and protect from the oxidative stress induced by amyloid deposition. The use of hormone replacement therapy (HRT) for the prevention and treatment of AD has received considerable attention. Treatment with conjugated equine oestrogens 0.625mg daily produces improvement during the third week, and this is maintained for as long as therapy is continued. Medroxyprogesterone acetate seems to have an unfavourable effect on AD, causing a depressive status. Therefore systemic oestrogen treatment with vaginally administered progesterone for endometrial protection may be a suitable combination for non hysterectomised women with AD. Recent epidemiological studies have suggested that oestrogen use is associated with a reduction in the relative risk of AD with greater protection with increasing dose and duration of use.

Keywords

Alzheimer's disease (AD)oestrogen replacement prevention apolipoprotein E neurone

Get full access to this article

View all access options for this article.

References

1. Klaiber

Broverman

Vogel . Estrogen therapy for severe persistent depression in women. Arch Gen Psychiat 1979; 36: 550–554.

2. Gerdes

Sonnendecker

Polokaw

. Psychological changes effected by estrogen-progesterone and clonidine treatment in climacteric women. Am J Obstet Gynec 1982; 142: 98–103.

3. Ohkura

Teshima

Isse

. Estrogen increases cerebral and cerebellar blood flows in postmenopausal women. J Nor Ame. Menopause Soc 1994; 1: 13–18.

4. Coyle

Price

Delong

. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 1983; 219: 1184–1190.

5. Pearson

RCA

Sofroniew

Cuello

. Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohisto-chemical staining for choline acetyltransferase. Brain Res 1983; 289: 375–379.

6. Whitehouse

Martino

Marcus

. Reductions in acetylcholine and nicotine binding in several degenerative diseases. Arch Neuro 1988; 45: 722–724.

7. Luine

. Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp Neurol 1985; 89: 484–490.

8. Morley

Rodriguez-Sierra

Clough

. Increase in hypothalamic nicotinic acetylcholine receptors in prepuberal female rats administered estrogen. Brain Res 1983; 453: 389–392.

9. Honjo

Tamura

Matsumoto . Estrogen as a growth factor to central nervous cells. Estrogen treatment promotes development of acetylcholinesterase positive basal forebrain neurons transplanted in the anterior eye chamber. J Steroid Biochem Mol Biol 1992; 41: 633–635.

10.

10. Honjo

Tanaka

Kashiwagi

. Senile dementia-Alzheimer's type and estrogen. Horm Metab Res 1995; 27: 204–207.

11.

11. Jaffe

Toran-Allerand

Greengared

Estrogen regulates metabolism of Alzheimer amyloid ~ precursor protein. J Biol Chem 1994; 269: 1306513068.

12.

12. Corder

Saunders

Strittmatter

. Gene dose of apolipoprotein E type 4 allele and risk of Alzheimer's disease in late onset families. Science 1993; 261: 921–923.

13.

13. Mazur-Kolecka

Frackowiak

Winsniewski

. Apolipoprotein E3 and E4 induce, and transthyretin prevents accumulation of the Alzheimer's beta-amyloid peptide in cultured vascular smooth muscle cells. Brain Res 1995; 698: 217–222.

14.

14. Urabe

Iwasa

Honjo

Effect of estrogen replacement therapy on hepatic triglyceride lipase, lipoprotein lipase and lipids including apolipoprotein E in climacteric and elderly women. Endocrine J 1996; 43: 737–742.

15.

15. Srivasta

RAK

Bhasin

Srivasta

Apolipoprotein E gene expression in various tissues of mouse and regulation by estrogen. Biochem and Mol Biol Intern 1996; 38: 91–101.

16.

16. Stone

Rozovsky

Morgan

. Astrocytes and microglia respond to estrogen with increased apo E mRNA in vivo and in vitro. Exp Neurol 1997; 143: 313–318.

17.

17. Behl

Widmann

Trapp

Holsboer

17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem Biophys Res Comm 1995; 216: 473–482.

18.

18. Fillit

Weinref

Cholst

. Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer's type. Psychoneuroendocrinology 1986; 11: 337–345.

19.

19. Honjo

Ogino

Naitoh

. Effects of estrogen at high or low dose to women complicated with senile dementia-Alzheimer's type. World Obstet Gynecol 1991; 43: 423–427.

20.

20. Honjo

Ogino

Naitoh

. In vivo effects by estrone sulfate on the central nervous system ~ senile dementia (Alzheimer's type). J Steroid Biochem 1989; 34: 521–525.

21.

21. Honjo

Ogino

Tanaka

. An effect of conjugated estrogen to cognitive impairment in women with senile dementia - Alzheimer's type: A placebo-controlled double blind study. J Jpn Menopause Soc 1993; 1: 167–171.

22.

22. Ohkura

Isse

Akazawa

. Low-dose estrogen replacement therapy for Alzheimer disease in women. J Nor Amer Menopause Soc 1994; 1: 125–130.

23.

23. Paganini-Hill

Henderson

. Estrogen replacement therapy and risk of Alzheimer's disease. Arch Intern Med 1996; 156:2213–2217.

24.

24. Tang

M-X

Jacobs

Stern

. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disase. Lancet 1996; 348: 429–432.

25.

25. Kwas

Rensick

Morrison

. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease; Baltimore Longitudinal Study of Aging. Neurology 1997; 48: 1517–1521.